Breaking News
July 18, 2018 - A 3-Pronged Plan to Cut Type 2 Diabetes Risk
July 18, 2018 - New clues to sepsis may speed diagnosis
July 18, 2018 - Stars of Stanford Medicine: Improving cardiovascular health in Africa and beyond
July 18, 2018 - Few tips to help avoid sunburns in summer
July 18, 2018 - Researchers develop 3D map of gene interactions that play key role in heart disease
July 18, 2018 - Conservative management of lung subsolid nodules reduces overtreatment and unnecessary surgery
July 18, 2018 - Report warns of dog illness that can spread to owners
July 18, 2018 - A winning essayist’s tips for keeping track of scientific facts
July 18, 2018 - Researchers seek to understand role of APOE mutation in Alzheimer’s disease
July 18, 2018 - Animal studies reveal brain changes responsible for appetite effects of cannabis
July 18, 2018 - New ZEISS ZEN Intellesis machine allows segmentation of correlative microscopy
July 18, 2018 - Study findings highlight importance of early detection of SMA through newborn screening
July 18, 2018 - Results of Phase III (PIX306) Trial Evaluating Progression-Free Survival of Pixuvri (pixantrone) Combined with Rituximab in Patients with Aggressive B-cell Non-Hodgkin Lymphoma
July 18, 2018 - Diabetes researchers find switch for fatty liver disease
July 18, 2018 - The future of the microbiome: A conversation
July 18, 2018 - States attacking ACA would hurt most if shield on preexisting conditions were axed
July 18, 2018 - Novel delivery system for bacteriophages could offer new way to battle lung infections
July 18, 2018 - PTSD may increase risk of stroke, heart attack in World Trade Center response crews
July 18, 2018 - Finding the right protective eyewear for young athletes
July 18, 2018 - Routine screening, treatment could help stem nationwide opioid epidemic
July 17, 2018 - AI and radar technologies could help diabetics manage their disease
July 17, 2018 - New Stanford algorithm could improve diagnosis of many rare genetic diseases
July 17, 2018 - Burdensome symptoms of eczema can lead to impaired quality of life, shows study
July 17, 2018 - Sartorius Stedim Biotech and Penn State partner to advance teaching, research in biotechnology
July 17, 2018 - Researchers map family trees of cancer cells to understand how AML responds to new drug
July 17, 2018 - Mortality from heart failure remains higher in women than men
July 17, 2018 - Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction
July 17, 2018 - AAP: Lawnmowers Pose Serious Injury Risk to Children
July 17, 2018 - Fewer U.S. kids are getting cavities
July 17, 2018 - Differences in brain’s reward circuit may explain social deficits in autism
July 17, 2018 - YCC researchers suggest promising treatment for two rare inherited cancer syndromes
July 17, 2018 - FAU and partners receive NIH research grant to shed light on sleep loss and metabolic disorders
July 17, 2018 - Advanced MRI technique predicts risk of disease progression in MS
July 17, 2018 - Health Tip: Microwave Safely – Drugs.com MedNews
July 17, 2018 - New target for treating heart failure identified
July 17, 2018 - Biodesign fellows simplify heart rhythm monitoring
July 17, 2018 - Study reveals new risk genes for allergic rhinitis
July 17, 2018 - Community college education can increase physician diversity and access to primary care
July 17, 2018 - Inflection Biosciences’ dual mechanism inhibitor shows promise as treatment for CLL
July 17, 2018 - Researchers uncover how cells invite corrupted proteins inside
July 17, 2018 - Large international study finds new risk genes for hay fever
July 17, 2018 - Studies show HORIBA’s new hematology analyzer improves POCT and care of oncology patients
July 17, 2018 - New website aims to make yoga safer for everyone
July 17, 2018 - Long-term survival worse for black survivors of in-hospital cardiac arrest
July 17, 2018 - Stanford data analyst’s childhood inspires his research: A Q&A
July 17, 2018 - Preventability of hospital readmissions changes over time, study reveals
July 17, 2018 - Nursing notes can help predict if ICU patients will survive
July 17, 2018 - Most older adults with probable dementia found to be either undiagnosed or unaware of it
July 17, 2018 - Vallum receives FDA clearance to market PEEK spinal interbody fusion device
July 17, 2018 - Okayama University research could improve prognosis of diabetic kidney disease
July 17, 2018 - Researchers develop machine learning method to predict unknown gene functions of microbes
July 17, 2018 - Homogenous BTK occupancy assay used in tirabrutinib clinical studies
July 17, 2018 - Study identifies new genes linked to heart function and development
July 17, 2018 - NeuroTrauma Sciences and Henry Ford join hands to advance exosome technology
July 17, 2018 - Improved methods to measure enterococci concentrations in recreational water
July 17, 2018 - White adolescent boys experiencing early puberty have high risk for substance use
July 17, 2018 - Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia
July 17, 2018 - Roots of leukemia reveal possibility of predicting people at risk
July 17, 2018 - Summer med program embraces low-income students’ potential
July 17, 2018 - New research lays foundation to create standards for RNA sequencing
July 17, 2018 - CRISPR/Cas9 gene editing can cause greater genetic damage than previously thought
July 17, 2018 - Democrats rally against threats to the ACA to block Trump’s Supreme Court nominee
July 17, 2018 - Staggering prices slow insurers’ coverage of CAR-T cancer therapy
July 17, 2018 - How proteins involved in neurodegeneration enter cells
July 17, 2018 - New super-resolution ‘nanoscope’ provides insight into progression of Alzheimer’s disease
July 17, 2018 - FDA Advisory Committee Endorses the Effectiveness and Safety of Single-Dose Tafenoquine for the Radical Cure of P. vivax Malaria
July 17, 2018 - Uncovering the evolutionary history of IBD-associated colorectal cancer
July 17, 2018 - Is nutrition research dependable? Stanford’s John Ioannidis weighs in
July 17, 2018 - New machine learning framework predicts effects of genetic mutations in ‘dark matter’ regions
July 17, 2018 - Plant-based products fail to have positive impact on blood pressure during clinical studies
July 17, 2018 - Electronic system to speed up facial pain diagnosis may improve quality of life and save money
July 17, 2018 - Study delves into the role played by Protein Kinase C in synaptic plasticity
July 17, 2018 - Women Often Unaware of Their Hospital’s Religious Affiliation
July 17, 2018 - New AASM guideline recommends use of actigraphy for sleep disorders
July 17, 2018 - CRISPR editing reduces repetitive behavior in mice with a form of autism
July 17, 2018 - Scientists use magnets to detect cancer
July 17, 2018 - Microfluidic chip to detect sepsis proves successful in clinical study
July 17, 2018 - Research provides better understanding of mechanisms underlying memory storage
July 17, 2018 - A Multi-Modal Approach for the Early Detection of Breast Cancer
July 17, 2018 - Mailing colorectal cancer tests to patients increases screening rates, report researchers
Can you rely on the drugs that your doctor prescribes?

Can you rely on the drugs that your doctor prescribes?

image_pdfDownload PDFimage_print
The reliability of a new guideline for the management of chronic hepatitis C is questionable, given the financial conflicts of interest documented by its authors. Credit: Shutterstock

The Canadian Medical Association Journal (CMAJ) has just published a new guideline for the management of hepatitis C—a disease that is underdiagnosed and undertreated in Canada.

This guideline is aimed at doctors and details recent advances in treating adults with chronic hepatitis C virus infection. It was produced by a committee from the Canadian Association for the Study of the Liver (CASL).

As the complexity of medical care grows exponentially, clinical guidelines such as this become increasingly important in helping doctors weave their way through the diagnosis and treatment of disease. As the number of guidelines increases, so too does their influence.

Well-constructed medical guidelines can be a boon to patient care, but poor guidelines have the potential for harm. There are two interrelated threats. The first is when committee members have a financial conflict of interest (FCOI) with companies producing products recommended in the guidelines. The second occurs when guidelines rely on poor quality evidence.

In the lead up to the Global Hepatitis Summit 2018, to be held in Toronto on June 14-17, we believe there are reasons to be concerned about this new hepatitis C guideline on both counts.

First, all eight authors of the CMAJ article, including the chair, declared FCOI with companies that produced the drugs recommended in the guideline. Second, the committee did not include an expert on evidence evaluation or someone representing the public or patients.

Do guidelines recommend the best drugs?

One of the authors of this article (Joel Lexchin) was part of a study that looked at FCOI in Canadian medical guidelines. We examined 28 guidelines that recommended drug treatment for a wide variety of diseases.

In more than 25 per cent of these documents, over half of the authors disclosed FCOI with manufacturers of drugs that they recommended.

The guideline for the treatment of patients with major depressive disorder from the American Psychiatric Association was studied by Lisa Cosgrove, the second author of this article. Financial ties to industry were disclosed by all members of this guideline development committee.

The presence of this FCOI may have been the reason why fewer than half of the studies cited in support of the recommendations met criteria for high quality and why 17 per cent did not measure clinically relevant results.

To guard against the corruption of guidelines, safeguards have been put in place. The U.S. Institute of Medicine (IOM), now the National Academy of Medicine, has recommendations about the membership on guideline committees. According to them, the chair and the majority of members should be free of FCOI and the committee should include an expert in the evaluation of evidence and a patient or public representative.

When the highly respected Cochrane organization produces medical guidelines, it explains in detail why studies are included or excluded. It also evaluates the multiple sources of bias that potentially exist in all studies.

The point about bias is extremely important as there is good evidence that studies financed by drug and device manufacturers are much more likely to report positive results and conclusions, compared with studies with any other source of funding.

Finally, guidelines produced by industry-tied authors tend to recommend expensive drugs despite a lack of evidence for their safety and efficacy.

3D illustration of the hepatitis C virus (HCV). Credit: Shutterstock

Silent on many questions

So, how valuable is a guideline for the management of hepatitis C, in which eight authors declared FCOI with recommended drug producers? How reliable are the recommendations from a committee that did not document how evidence was evaluated or include a public or patient representative?

The committee did attempt to get around some of these deficiencies. First the guideline explicitly states: “No funding, direct or in kind, was provided to the guideline panel for this work.” Second, “in order to manage competing interests, the final guideline was vetted by the Canadian Association for the Study of the Liver membership, and specifically by the association’s executive.” Third, the “guideline was circulated by email to community organizations that represented patients.”

Who were the community organizations and did they have ties with the companies making the drugs the guideline recommends? The guideline is silent on these questions.

Who is on the executive of CASL? Do they as individuals have links with industry? Does the association itself have links?

Getting even partial answers to these questions requires some digging. A simple Google search on “Canadian Association for the Study of the Liver” doesn’t produce any direct links. The closest is a link to the Canadian Liver Journal. Visit this page, click around a few more times and eventually you get to the CASL website.

There are 33 people on the executive board including three of the guideline committee members; so, executive committee members were reviewing what they themselves had written.

Did the other 30 members have any FCOI to declare? There’s no information about these people on the website. The website does say that CASL only endorses requests produced by a not-for-profit organization and that it “does not endorse or support any commercial diagnostic or therapeutic products.”

But Gilead Science, Merck and AbbVie were all 2018 sponsors of Association Hepatology Fellowships. Gilead and AbbVie both produce hepatitis C drugs and Merck was working in this field until October 2017.

Does CASL get money from drug companies? Silence once more.

There is nothing in the guideline about why studies were included or excluded, nothing about how the information was abstracted from the studies and nothing about whether they were checked for biases.

Guidelines must be bias-free

The appearance of this guideline in the CMAJ raises serious questions about the journal’s standards for publishing guidelines. The article was peer reviewed and FCOI was declared, but should the journal do more?

Should it require the composition of guideline committees to conform to the standards set by the National Academy of Medicine?

Should there have to be information about FCOI of the organization sponsoring the guidelines?

Should there have to be explicit information about how studies were selected and evaluated?

Guidelines have to be seen as free of bias in order for doctors to have confidence in them. The new hepatitis C guideline published by the Canadian Medical Association Journal fails the bias test.


Explore further:
Hepatitis C guideline recommends screening for all people born 1945-1975

Journal reference:
Canadian Medical Association Journal

Provided by:
The Conversation

About author

Related Articles